Treasury Wine Estates reports a robust first half of 2025, driven by luxury portfolio growth and DAOU integration, while premium segments face headwinds.
Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.